FNV:NYSEFranco-Nevada Corporation Analysis
Data as of 2026-07-27 - not real-time
$214.21
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Fundamentals: Franco‑Nevada delivers exceptional revenue growth and ultra‑high profit margins, operates debt‑free with ample cash, and sustains a modest dividend payout that leaves room for further distribution. The royalty‑stream model provides resilient cash generation across a diversified portfolio of precious‑metal assets.
Technical outlook: The share price sits below the short‑, medium‑ and long‑term moving averages, signaling a bearish trend, yet the MACD histogram is positive and the signal line has turned bullish, suggesting a potential short‑term reversal. RSI hovers around the neutral zone, volume is on an upward trajectory, and the price is anchored above a clear support level while facing resistance near the 220‑point area. The discounted cash‑flow estimate exceeds the current market price, and analyst consensus targets imply a material upside, reinforced by an “Extreme Greed” market sentiment.
Technical outlook: The share price sits below the short‑, medium‑ and long‑term moving averages, signaling a bearish trend, yet the MACD histogram is positive and the signal line has turned bullish, suggesting a potential short‑term reversal. RSI hovers around the neutral zone, volume is on an upward trajectory, and the price is anchored above a clear support level while facing resistance near the 220‑point area. The discounted cash‑flow estimate exceeds the current market price, and analyst consensus targets imply a material upside, reinforced by an “Extreme Greed” market sentiment.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near technical support
- bullish MACD crossover
- increasing trading volume
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- valuation gap to DCF fair value
- strong revenue growth and margins
- analyst price targets indicating upside
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- debt‑free balance sheet with solid cash position
- sustainable dividend and low payout ratio
- diversified global royalty portfolio offering long‑term gold exposure
Key Metrics & Analysis
Financial Health
Revenue Growth77.70%
Profit Margin65.67%
P/E Ratio30.1
ROE19.04%
ROA13.02%
P/B Ratio5.1
Op. Cash Flow$1.7B
Free Cash Flow$-827950016
Technical Analysis
TrendBearish
RSI53.7
Support$195.29
Resistance$220.00
MA 20$207.58
MA 50$216.87
MA 200$225.80
MACDBullish
VolumeIncreasing
Fear & Greed Index87.3
Valuation
Fair Value$221.74
Target Price$277.17
Upside/Downside29.39%
GradeUndervalued
TypeBlend
Dividend Yield0.82%
Risk Assessment
Beta1.05
Volatility38.78%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.